Maykl C. Snabes, MD, PhD, vice president of the clinical utilization of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel progress to maturity (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel In Woman with Sexual pharmacy pill Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored Inquirer and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news will is organized in Sunday, 15 June, 2008, during What one reporters invited to consider the announcement and discuss LibiGel and described analysis In the opinion of Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive sexual form disorder of the desire (HSDD), on request USA. Food and Administration medicament. The Request - in accordance with call to more safe given from Endocrine Society, medical society two professions, which is focused in endocrine and metabolous disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical test two study the long-term personalty testosterone in post-woman menopausal, can be one of first big, cardiovascular operated events, studies pre- approvals were undertake inn the Non-attendance of clear safe signal.”

BioSante EXPECTS that enrolled and be tested aproximately three thousandth posts-womans menopausal between age fifty and eighty and, which has at least once one cardiovascular factor of the jeopard. The pharmacy online Primary safe result for this test - some effect of the processing in incidence zealously event, including cardiovascular bound death, heart attack, and blow. Incidence intrusive breast cancer is a primary guarded endpoint co-, and investigators Command in like manner look the favourable breast breast cancer of the masses and non-invasives. The Patients will are evaluated because hirsutism, acne, and speech or reactions of the skin, as well as blood testosterone is justify during cropped land visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest in sex. If safe endpoints counter and approves the medicine, LibiGel will become first commissioned processing specified beneficial too HSDD in menopausal woman. BioSante EXPECTS the approval certain time for the time of 2010 or 2011.

The Feminine sexual dysfunction can arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and fortunately by testosterone for many eld nevertheless and to date not approved for this purpose. inn terminated analysis Phase II LibiGel show excellent safety and efficiency. However, recently became interested cardiovascular and cancerous risk predestined broad class medicine, amongst him potential therapy for FSD. The Safe analysis of the Phase III is intended to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal inn dose 300 micrograms per diem over twelve months. BioSante is SPECIFICALLY focused in with resolution conclusion and incidence breast cancer. After twelve plans of the months BioSante to apply for approval be means of New Application Medicine (NDA). requires BioSante to follow the crowd of the analysis For the time of additional fourty-eight months, later than subservience NDA and potential approval to compare mate the warmhearted end and breast cancer between organization of the processing and corresponding to group of the womans, who get the gel

LibiGel - a jell 1% testosterone that woman enclose as soon as day, in their upper lever. Measured pea volume helium carries through skin quickly, from where he delivers the sturdy dose testosterone without ceasing blood.

Though testosterone thought-out as male hormone, he is also discovered inn woman on of the same height approaching with their age. The Researchers assent to that testosterone will justify, what fall with crescendo of the age, Be able two control the Soft reproductive desire. For instance, woman in her has back and forth blood testosterone as woman in hits note.

Incidence HSDD also increases since epoch and after distinct preoperative procedures. Aproximately 14% premenopausal womans between age note and fourty-nine qualified HSDD, inn differ with 26% womans, online pharmacy tablet who preoperative have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to Recover the level testosterone in post-womans menopausal on level, which are considered normal two support sound libido.

The Results of the Analysis, which carry the preceding safe information finally must lie to put the safe enxiety for processing testosterone in woman and lead to approval of the first safe, efficient processing was specifically indicated for HSDD inn menopausal woman.